CNS Neoplasm (Primary Tumor) - Astrocytoma, Low Grade
NCT03213691
Clinical Trial Information
Trial Number: NCT03213691 (ClinicalTrials.gov)
Disease Type:
- CNS Neoplasm (Primary Tumor) - Astrocytoma, High Grade
- CNS Neoplasm (Primary Tumor) - Astrocytoma, Low Grade
- CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
- Soft Tissue Neoplasm - Rhabdomyosarcoma
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial"
Study ID:
APEC1621E
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
NCT00003375
Clinical Trial Information
Trial Number: NCT00003375 (ClinicalTrials.gov)
Disease Type:
- CNS Neoplasm (Primary Tumor) - Astrocytoma, Low Grade
- CNS Neoplasm (Primary Tumor) - Oligodendroglial Tumors
Trial Title:
A PHASE II STUDY OF OBSERVATION IN FAVORABLE LOW-GRADE GLIOMA AND A PHASE III STUDY OF RADIATION WITH OR WITHOUT PCV CHEMOTHERAPY IN UNFAVORABLE LOW-GRADE GLIOMA
Study ID:
RTOG 9802
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
NCT03722355
Clinical Trial Information
Trial Number: NCT03722355 (ClinicalTrials.gov)
Disease Type:
- CNS Neoplasm (Primary Tumor) - Astrocytoma, Low Grade
Trial Title:
Phase III comparison of hyperfractionated Radiation Therapy (RT) with BCNU and conventional RT with BCNU for Supratentorial Malignant Glioma
Study ID:
RTOG-90-06
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT03722355-D1 | This dataset will allow users to reproduce the treatment comparison between arm 1 and arm 2 in trial NCT03722355. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®